Filing Details
- Accession Number:
- 0001209191-20-057828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 08:18:00
- Reporting Period:
- 2020-11-10
- Accepted Time:
- 2020-11-12 08:18:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197036 | I Bruce Sachs | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-10 | 6,825 | $216.47 | 18,035 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-10 | 4,270 | $217.49 | 22,305 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-10 | 3,905 | $218.79 | 26,210 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Open market purchases reported on this line occurred at a weighted average price of $216.47 (range $216.01 to $217.00).
- Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
- Open market purchases reported on this line occurred at a weighted average price of $217.49 (range $217.05 to $218.04).
- Open market purchases reported on this line occurred at a weighted average price of $218.79 (range $218.21 to $219.00).